These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 31450762)
21. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug. Prabha G; Raj V Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054 [TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency. Ghosh S; Dutta S; Sarkar A; Kundu M; Sil PC Colloids Surf B Biointerfaces; 2021 Jan; 197():111404. PubMed ID: 33142257 [TBL] [Abstract][Full Text] [Related]
23. Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy. Li T; Shen X; Geng Y; Chen Z; Li L; Li S; Yang H; Wu C; Zeng H; Liu Y ACS Appl Mater Interfaces; 2016 Jun; 8(22):13748-58. PubMed ID: 27191965 [TBL] [Abstract][Full Text] [Related]
24. Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells. Zheng G; Shen Y; Zhao R; Chen F; Zhang Y; Xu A; Shao J J Agric Food Chem; 2017 Aug; 65(32):6904-6911. PubMed ID: 28771340 [TBL] [Abstract][Full Text] [Related]
25. Tumor targeted delivery of umbelliferone via a smart mesoporous silica nanoparticles controlled-release drug delivery system for increased anticancer efficiency. Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111239. PubMed ID: 32806268 [TBL] [Abstract][Full Text] [Related]
26. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles. Yan Y; Fu J; Wang T; Lu X Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940 [TBL] [Abstract][Full Text] [Related]
27. Improved Gene Transfer with Functionalized Hollow Mesoporous Silica Nanoparticles of Reduced Cytotoxicity. Zhan Z; Zhang X; Huang J; Huang Y; Huang Z; Pan X; Quan G; Liu H; Wang L; Wu AC Materials (Basel); 2017 Jun; 10(7):. PubMed ID: 28773087 [TBL] [Abstract][Full Text] [Related]
28. Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy. Wang J; Wang Y; Liu Q; Yang L; Zhu R; Yu C; Wang S ACS Appl Mater Interfaces; 2016 Oct; 8(40):26511-26523. PubMed ID: 27619078 [TBL] [Abstract][Full Text] [Related]
29. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. He Y; Liang S; Long M; Xu H Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():12-17. PubMed ID: 28575958 [TBL] [Abstract][Full Text] [Related]
30. Effects of pore size on Li J; Shen S; Kong F; Jiang T; Tang C; Yin C RSC Adv; 2018 Jul; 8(43):24633-24640. PubMed ID: 35539161 [TBL] [Abstract][Full Text] [Related]
31. Hyaluronidase-Responsive Mesoporous Silica Nanoparticles with Dual-Imaging and Dual-Target Function. Wu ZY; Lee CC; Lin HM Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137518 [TBL] [Abstract][Full Text] [Related]
32. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement. Hartono SB; Hadisoewignyo L; Yang Y; Meka AK; Antaresti ; Yu C Nanotechnology; 2016 Dec; 27(50):505605. PubMed ID: 27875331 [TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells. Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941 [TBL] [Abstract][Full Text] [Related]
34. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839 [TBL] [Abstract][Full Text] [Related]
35. Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin. Gao Y; Ding S; Huang X; Fan Z; Sun J; Hai Y; Li K Drug Dev Ind Pharm; 2019 Feb; 45(2):273-281. PubMed ID: 30346852 [TBL] [Abstract][Full Text] [Related]